About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

CD180 Overexpression in Follicular Lymphoma

NCT02978898·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Hospices Civils de Lyon

Age

18–any

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

Samples from patients with:
* LF: Follicular lymphoma
* MCL: Mantle cell lymphoma
* CLL/SLL: chronic lymphocytic leukemia/small lymphocytic leukemia
* MZL : splenic marginal zone
* Clt :control B-cells

You may not be if

Patient \<18 years old

The record

StatusCompleted

PhaseNo phase

Taking part184

StartedJun 2012

UpdatedDec 1, 2016

Conditions

Follicular Lymphoma

Clareo Health | CD180 Overexpression in Follicular Lymphoma